Serum Life Science Europe

Serum Life Science Europe is the European manufacturing and operational arm of the Serum Institute of India, the world's largest vaccine producer by volume. The company was established in 2020 through the acquisition of a state-of-the-art manufacturing facility in Reinbek, Germany, previously owned by Merck KGaA's Allergopharma business. This facility serves as a strategic hub for the production, fill-finish, and distribution of vaccines and biologics for the European and global markets. By integrating this European site into its global network, the company enhances its supply chain resilience and capacity to deliver affordable life-saving medicines. The entity focuses on high-standard GMP manufacturing of diverse biological products, including vaccines for infectious diseases. It plays a vital role in the Serum Institute's mission to provide affordable healthcare solutions globally.